Trial Profile
Efficacy and tolerability of PROMUS Element Plus everolimus-eluting platinum-chromium coronary stent vs OMEGA platinum bare metal stent in patients with acute myocardial infarction: the HORIZONS II AMI trial.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Aug 2013
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Clopidogrel; Prasugrel
- Indications Coronary artery restenosis; Myocardial infarction
- Focus Registrational; Therapeutic Use
- Acronyms HORIZONS-II-AMI
- 26 Mar 2013 Status changed from planning to recruiting, as reported in a Cardiovascular Research Foundation media release.
- 28 Mar 2012 New trial record